Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BMP1 | P13497 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.36 |
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | NMT2 | O60551 | 1/20 | 0.33 |
| ▸ | NMT1 | P30419 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.32 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.31 |
| ▸ | MMP9 | P14780 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12018363 | 0.87 | BMP1 (0.44) | BMP1DPP4DPP8DPP9TASP1 | |
| SCHEMBL14553976 | 0.84 | BMP1 (0.51) | BMP1DPP4DPP8DPP9TASP1 | |
| SCHEMBL16656707 | 0.82 | KMT2A (0.40) | BMP1DPP4DPP8DPP9KMT2A | |
| SCHEMBL13233708 | 0.82 | KMT2A (0.40) | BMP1DPP4DPP8DPP9KMT2A | |
| SCHEMBL12930062 | 0.82 | KMT2A (0.40) | BMP1DPP4DPP8DPP9KMT2A | |
| SCHEMBL14553986 | 0.82 | BMP1 (0.40) | BMP1DPP4DPP8DPP9NMT2 | |
| SCHEMBL18671026 | 0.81 | NOD1 (0.46) | BMP1KMT2ANMT2NMT1NOD1 | |
| SCHEMBL10084422 | 0.77 | BMP1 (0.51) | BMP1DPP4DPP8DPP9KMT2A | |
| SCHEMBL21172264 | 0.77 | BMP1 (0.51) | BMP1DPP4DPP8DPP9KMT2A | |
| SCHEMBL14490962 | 0.77 | KMT2A (0.41) | BMP1DPP4DPP8DPP9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100056433-A1 | Novel Peptides for Use in the Treatment of Obesity | NOVO NORDISK A/S (DK) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056433-A1 | Novel Peptides for Use in the Treatment of Obesity | MC4R, MC3R, GIPR | BMP1 1317/4885DPP4 100/4885DPP8 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.